Trial intelligence / Profile preview

Evaluation of Levamisole Efficacy in Treatment of COVID-19

IRCT20190810044500N7Phase 2Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of levamisole in coronavirus disease 2019 (COVID-19), sponsored by Shahid Sadoughi University of Medical Sciences. Started Apr 2020; status: completed.

02

Drugs

levamisole
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on IRCT20190810044500N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190810044500N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call